Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CP.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.39EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.40EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.3.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BM.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.57EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EF.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BW.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CK.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.8.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CA.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.61EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
ED.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BU.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.3.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCGEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.30EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DT.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DT.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCAEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.50EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.54EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GN.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.77 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.53 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.599EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.128EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.451EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.313EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.402EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.609EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.344EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.556EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.245EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.403EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.636EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.126EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.47EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDQ.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JD.1.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.31.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used